Topiramate (PrevEp)

N/A

Report date: 2024/03/28 17:59:11

Base Information

Drug NameTopiramate (PrevEp)
Drug Alias NamePrevEp-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonistsSodium channels blockersGamma-aminobutyric acid A receptor antagonists +[5] 
TargetsGlutamate receptor ionotropic AMPASodium channelsGamma-aminobutyric acid A receptor +[5] 
Therapy Area/IndicationsStatus EpilepticusEpilepsy, Benign Neonatal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrevEP Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrevEP Inc
Inactive CompaniesN/A
Active IndicationsStatus EpilepticusEpilepsy, Benign Neonatal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A